FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/09/074471 [Registered on: 27/09/2024] Trial Registered Prospectively
Last Modified On: 26/09/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   Clinical study of Kshaumadi karnadhoopana and Rasnaadi guggulu in Karnasrava (CSOM) 
Scientific Title of Study   Clinical Evaluation Of Kshaumadi Karnadhoopana And Rasnaadi Guggulu in Karnasrava (Chronic Suppurative Otitis Media) 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Arun Kumar 
Designation  Assistant Professor (Shalakya Tantra) 
Affiliation  Rishikul Campus Haridwar Uttarakhand Ayurved University (Dehradun) 
Address  O.P.D No 05 P.G. Department of Shalakya Tantra Rishikul Campus Haridwar Uttarakhand Ayurved University (Dehradun) Hardwar UTTARANCHAL 249401 India

Hardwar
UTTARANCHAL
249401
India 
Phone  9634918909  
Fax    
Email  drarun2004@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Arun Kumar 
Designation  Assistant Professor (Shalakya Tantra) 
Affiliation  Rishikul Campus Haridwar Uttarakhand Ayurved University (Dehradun) 
Address  O.P.D No 05 P.G. Department of Shalakya Tantra Rishikul Campus Haridwar Uttarakhand Ayurved University (Dehradun) Hardwar UTTARANCHAL 249401 India

Hardwar
UTTARANCHAL
249401
India 
Phone  9634918909  
Fax    
Email  drarun2004@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Sandhya Tewari 
Designation  PG Scholar (Shalakya Tantra) 
Affiliation  Rishikul Campus Haridwar Uttarakhand Ayurved University (Dehradun) 
Address  O.P.D No 05 P.G. Department of Shalakya Tantra Rishikul Campus Haridwar Uttarakhand Ayurved University (Dehradun) Hardwar

Hardwar
UTTARANCHAL
249401
India 
Phone  7017727655  
Fax    
Email  tewarisandhya355@gmail.com  
 
Source of Monetary or Material Support  
Rishikul Campus,Uttrakhand Ayurved University,Haridwar,249401,India 
 
Primary Sponsor  
Name  Uttarakhand Ayurved University Dehradun 
Address  Uttarakhand Ayurved University, Station Road, Harrawala, Dehradun-248001 Uttarakhand, India  
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sandhya Tewari  Rishikul Ayurvedic College  O.P.D No 05, P.G. Department of Shalakya Tantra, Haridwar, Uttarakhand Ayurved University (Dehradun) Hardwar UTTARANCHAL 249401 India
Hardwar
UTTARANCHAL 
7017727655

tewarisandhya355@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee, Uttarakhand Ayurved University, Rishikul Campus, Haridwar  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:H661||Chronic tubotympanic suppurative otitis media. Ayurveda Condition: KARNA-SRAVAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Rasnaadi guggulu, Reference: Yogratnakar, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 21 Days, anupAna/sahapAna: Yes(details: -lukewarm water), Additional Information: -
2Intervention ArmProcedure-karNadhUpanam, कर्णधूपनम् (Procedure Reference: Sushruta samhita, Procedure details: This procedure will be done for 21 days in three sittings of 5-5 days with a gap of 3 days in each sitting.Total duration of procedure is 10 minutes.)
(1) Medicine Name: Kshaumadi , Reference: Sushruta samhita, Route: Topical, Dosage Form: Not Applicable, Dose: 8(g), Frequency: od, Duration: 21 Days
 
Inclusion Criteria  
Age From  16.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1.Patients willing to register
2.Patients within the age group of 16-60 years
3.Patients having specific signs and symptoms of CSOM and karnasrava
4.Tubotympanic (SAFE) type of CSOM
5.Active cases of Tubotympanic CSOM with chronicity less than 2yrs 
 
ExclusionCriteria 
Details  1 Patients not willing to participate in the study.
2 Pregnant women and lactating mothers.
3 Patients with the complications of CSOM.
4 Systemic diseases like DM, Meningitis, Tuberculosis, etc.
5 Atticoantral (Unsafe) type of CSOM.
6 Non- vaccinated Covid-19 patients.  
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Relief in sign and symptoms-
a)Earache
b)Discharge
c)Consistency of discharge
d) TM perforation size
e) External examination by torch and otoscopic examination to rule out TM perforation size
f)Hearing assessment done by PTA,Rinne and Weber test
 
Followup at an interval of 15 days and 30 days. 
 
Secondary Outcome  
Outcome  TimePoints 
Relief in sign & symptoms-
a)Earache
b)Discharge
c)Consistency of discharge
d) TM perforation size
e) External examination by torch & otoscopic examination to rule out TM perforation size

 
Followup at interval of 15 days & 30 days 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   08/10/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Among 28 ear diseases mentioned by Acharya Sushruta Karnasrava is one of them. Available treatment protocols for CSOM in modern system of medicine relies upon  antibiotics and pain killers.

CSOM is a frustrating entity for both patients and otolaryngologists as it requires long term treatment and medications used for its treatment has limitations like acidity, loss of hearing and unusual taste in mouth.

So the present study will be planned to study the effect of Ayurvedic formulation on Karnasrava.

Case will be selected from OPD/IPD of Rishikul Campus Hospital, U.A.U. Haridwar (UK) INDIA.

A written informed consent will be obtained after counselling of patients participating in the study.

Patients will be treated with Dhoopana therapy, local application and oral drug.
 
Close